Crossmark

PIK3CA mutations and specific treatment: do not forget lessons from RAS mutations and EGFR targeting

Published Online: 2020-01-22

Published Print: 2020-02

Authors

Milano, Gérard
License Information

Text and Data Mining valid from 2020-01-22

Version of Record valid from 2020-01-22
More Information

Article History

Received: 2 September 2019

Accepted: 17 December 2019

First Online: 22 January 2020

Compliance with ethical standards

:

: The author declares that he has no conflict of interest.

Document is current